Table of contents
- Preliminary material
- Title page and verso
- Contents
- List of tables
- List of figures
- Acknowledgments
- Abbreviations
- Sections
- Introduction
- Why do we need a national collection?
- Brief history of the national collection
- Roles and responsibilities
- Scope of the AODTS-NMDS
- Which agencies?
- Which clients?
- Which activities?
- What's new for 2002-03?
- Treatment episodes reported by all jurisdictions
- Changes to existing data elements
- The data elements - in brief
- Establishment-level data elements
- Client-level data elements
- Supporting data element concepts
- Collection procedures and data quality
- Collation of the national data set
- Data transfer
- Data quality
- AIHW validation checks
- AIHW validation checks
- Privacy and confidentiality of data
- Privacy - an introduction
- Privacy and the AIHW
- Introduction
- End matter
- References
- Appendixes
- Appendix A: IGCD NMDS Working Group
- Appendix B: Data definitions - NHDD extracts
- Appendix C: Notes on ABS classifications
- Appendix D: Common methods of use for selected drugs of concern
- Appendix E: Extract of information Privacy Principles from the Privacy Act 1988.
Some detail on the National Privacy Principles (for private sector organisations)